JFG
NKTR icon

Jefferies Financial Group’s Nektar Therapeutics NKTR Stock Holding History

Jefferies Financial Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
+38,165
New +$2.79M 0.02% 583
2026
Q1 		– Sell
-111,900
Closed -$4.73M – 2061
2025
Q4 		$4.73M Sell
111,900
-191,300
-63% -$10.7M 0.02% 498
2025
Q3 		$17.3M Buy
+303,200
New +$10M 0.08% 161

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jefferies Financial Group's NKTR Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 38,165 shares worth $2.66M. The stake represents 0.02% of the portfolio and ranks #583 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in NKTR as recently as Q4 2025.

Jefferies Financial Group first reported a position in NKTR in Q3 2025 and has held it in 3 quarters since. The position peaked at $17.3M in Q3 2025. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Jefferies Financial Group held 38,165 shares of Nektar Therapeutics worth $2.66M as of Q2 2026.
  • Nektar Therapeutics was a new Jefferies Financial Group position in Q2 2026.
  • Nektar Therapeutics made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #583 holding.
  • Jefferies Financial Group first reported a position in Nektar Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Jefferies Financial Group's Nektar Therapeutics position peaked at $17.3M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.